News | February 23, 2023
Research underscores Beyfortus’ potential to prevent RSV disease in infants
The new Beyfortus data are consistent with all data accumulated to date and confirm its strong profile
The new Beyfortus data are consistent with all data accumulated to date and confirm its strong profile
The forecast across the seven years between 2022 and 2028 saw an average decline of 7%, resulting in a $10 billion drop in the total forecast sales between 2021 and 2028
Two biopharmaceutical experts join SK bioscience to strengthen the future strategies
India is working towards augmenting health infrastructure and have initiated multiple schemes to strengthen health systems and improve health service delivery
The current ruling will assure the safety of the use of Ranitidine for Indian patients
The two-day event focused on the multi-faceted relationship of clinical research stakeholders and looked at bridging the academic and clinical research gap.
This is the fifth consecutive year that a Biocon Group company has made it to the Asia lP ELITE list
Viehbacher brings extensive international experience in large pharmaceutical and entrepreneurial biotech companies
68% of children on a higher dose of Dupixent achieved histological disease remission at week 16
Subscribe To Our Newsletter & Stay Updated
